Text Size

Nutrition Effects on Fatigue During Tennis Playing

This study has been completed.
Sponsor:
Collaborators:
Service de Médecine du Sport et des Explorations Fonctionnelles - CHU G Montpied - Clermont-Ferrand
Laboratoire BAPS - Université Blaise Pascal - Clermont-Ferrand
Information provided by:
Lescuyer Laboratory
ClinicalTrials.gov Identifier:
NCT01353872
First received: May 13, 2011
Last updated: NA
Last verified: May 2011
History: No changes posted
  Purpose

The main objective of this study is to investigate the effects of ingestion of different sports drinks (Nutrattente / Nutraperf / Nutrarecup) on fatigue induced by a tennis tournament simulation.


Condition Intervention
Fatigue
 Dietary Supplement: Nutrattente / Nutraperf / Nutrarecup
Dietary Supplement: Nutrattente placebo / Nutraperf placebo / Nutrarecup placebo

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Double Blind (Subject, Caregiver, Investigator)
Official Title: Effects of Ingestion of Different Sports Drinks on Fatigue During Playing Tennis

Resource links provided by NLM:

MedlinePlus related topics: Fatigue
U.S. FDA Resources

Further study details as provided by Lescuyer Laboratory:

Primary Outcome Measures:
  • peripheral fatigue measured by surface electromyographic (EMG) signal from the right triceps muscle [ Time Frame: 3 matches (1.5 days) ] [ Designated as safety issue: No ]

Enrollment: 8
Study Start Date: October 2010
Study Completion Date: May 2011
Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Sports Drinks
3 drinks : Nutrattente (before each match) / Nutraperf (during each match) / Nutrarecup (after each match)
 Dietary Supplement: Nutrattente / Nutraperf / Nutrarecup
500 mL of Nutrattente before each match 500 mL/h of Nutraperf during each match 250 mL of Nutrarecup after each match
Placebo Comparator: Placebo
3 drinks : Nutrattente placebo (before each match) / Nutraperf placebo(during each match) / Nutrarecup placebo (after each match)
 Dietary Supplement: Nutrattente placebo / Nutraperf placebo / Nutrarecup placebo
500 mL of Nutrattente placebo before each match 500 mL/h of Nutraperf placebo during each match 250 mL of Nutrarecup placebo after each match

  Eligibility

Ages Eligible for Study:   18 Years to 35 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • About 18 to 35 years (inclusive) Subject has a stable weight for at least three months before the start of the study
  • Subject able and willing to comply with the protocol and agreeing to give their consent in writing
  • Subject affiliated with a social security scheme
  • Subject willing to be included in the national register of volunteers who lend themselves to biomedical research
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01353872

Locations
France
Sirvent
Aubiere, France, 63177
Sponsors and Collaborators
Lescuyer Laboratory
Service de Médecine du Sport et des Explorations Fonctionnelles - CHU G Montpied - Clermont-Ferrand
Laboratoire BAPS - Université Blaise Pascal - Clermont-Ferrand
Investigators
Study Director: Sebastien Peltier, PhD Lescuyer Laboratory
  More Information

No publications provided

Responsible Party: Peltier, Lescuyer Laboratory
ClinicalTrials.gov Identifier: NCT01353872     History of Changes
Other Study ID Numbers: 2010-A00724-35
Study First Received: May 13, 2011
Last Updated: May 13, 2011
Health Authority: France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
France: Committee for the Protection of Personnes

Keywords provided by Lescuyer Laboratory:
Fatigue
Tennis
Nutrition
Tournament simulation
Delivery of Health Care

Additional relevant MeSH terms:
Fatigue
Signs and Symptoms

ClinicalTrials.gov processed this record on May 23, 2013